Similar articles

• Prevention of loss of vertebral bone density in heart transplant patients.

  Muchmore JS, Cooper DK, Ye Y, Schlegel V, Pribil A, Zuhdi N. Muchmore JS, et al. J Heart Lung Transplant. 1992 Sep-Oct;11(5):959-63; discussion 963-4. J Heart Lung Transplant. 1992. PMID: 1420245
• Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.

  Kapetanakis EI, Antonopoulos AS, Antoniou TA, Theodoraki KA, Zarkalis DA, Sfirakis PD, Chilidou DA, Alivizatos PA. Kapetanakis EI, et al. J Heart Lung Transplant. 2005 May;24(5):526-32. doi: 10.1016/j.healun.2004.02.016. J Heart Lung Transplant. 2005. PMID: 15896748
• A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin.

  Välimäki MJ, Kinnunen K, Volin L, Tähtelä R, Löyttyniemi E, Laitinen K, Mäkelä P, Keto P, Ruutu T. Välimäki MJ, et al. Bone Marrow Transplant. 1999 Feb;23(4):355-61. doi: 10.1038/sj.bmt.1701586. Bone Marrow Transplant. 1999. PMID: 10100579 Clinical Trial.
• Treatment of osteoporosis.

  Eastell R, Riggs BL. Eastell R, et al. Obstet Gynecol Clin North Am. 1987 Mar;14(1):77-88. Obstet Gynecol Clin North Am. 1987. PMID: 3306525 Review.
• Medical management of osteoporosis. Fracture prevention.

  Brunelli MP, Einhorn TA. Brunelli MP, et al. Clin Orthop Relat Res. 1998 Mar;(348):15-21. Clin Orthop Relat Res. 1998. PMID: 9553528 Review.